These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6105420)

  • 1. Valproate, hyperammonaemia, and hyperglycinaemia.
    Jaeken J; Casaer P; Corbeel L
    Lancet; 1980 Aug; 2(8188):260. PubMed ID: 6105420
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium valproate and hyperglycinaemia.
    Bartlett K
    Lancet; 1977 Oct; 2(8040):716. PubMed ID: 71523
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of anticonvulsants on fasting plasma ammonia and amino acid levels.
    Verity CM; Applegarth DA; Farrell K; Kirby LT
    Clin Biochem; 1983 Dec; 16(6):344-5. PubMed ID: 6420086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced stimulation of renal ammonia production and excretion in the rat.
    Ferrier B; Martin M; Baverel G
    J Clin Chem Clin Biochem; 1988 Feb; 26(2):65-7. PubMed ID: 3130456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium valproate, pregnancy, and neonatal hyperglycinaemia.
    Similä S; von Wendt L; Hartikainen-Sorri AL; Kääpä P; Saukkonen AL
    Arch Dis Child; 1979 Dec; 54(12):985-6. PubMed ID: 119490
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic effects of prostatectomy.
    Hamilton Stewart PA; Barlow IM
    J R Soc Med; 1989 Dec; 82(12):725-8. PubMed ID: 2614764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylmalonic acidaemia and nonketotic hyperglycinaemia. Clinical and biochemical aspects.
    Corbeel L; Tada K; Colombo JP; Eeckels R; Eggermont E; Jaeken J; Den Tandt W; Harvengt L; Delhaye J; Deloecker W
    Arch Dis Child; 1975 Feb; 50(2):103-9. PubMed ID: 236734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate-induced inhibition of urea synthesis and hyperammonaemia in healthy subjects.
    Hjelm M; Oberholzer V; Seakins J; Thomas S; Kay JD
    Lancet; 1986 Oct; 2(8511):859. PubMed ID: 2876297
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
    Coulter DL; Allen RJ
    Lancet; 1980 Jun; 1(8181):1310-1. PubMed ID: 6104123
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of valproate-induced hyperammonemia in normal subjects by carbohydrate intake.
    Warter JM; Marescaux C; Chabrier G; Rumbach L; Micheletti G; Reitzer B; Hirsch E; Imler M
    Neurology; 1984 Nov; 34(11):1487-9. PubMed ID: 6436732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylate potentiates valproate-induced hyperammonemia in the rat.
    Uetrecht JP
    Pharmacology; 1987; 34(5):279-85. PubMed ID: 3112809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renal origin of sodium valproate-induced hyperammonemia in fasting humans.
    Warter JM; Brandt C; Marescaux C; Rumbach L; Micheletti G; Chabrier G; Krieger J; Imler M
    Neurology; 1983 Sep; 33(9):1136-40. PubMed ID: 6412158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency.
    Oechsner M; Steen C; Stürenburg HJ; Kohlschütter A
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):680-2. PubMed ID: 9598692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism for valproate-induced hyperammonemia.
    Coude FX; Rabier D; Cathelineau L; Grimber G; Parvy P; Kamoun PP
    Pediatr Res; 1981 Jun; 15(6):974-5. PubMed ID: 6787550
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic and renal contributions to valproic acid-induced hyperammonemia.
    Marini AM; Zaret BS; Beckner RR
    Neurology; 1988 Mar; 38(3):365-71. PubMed ID: 3126407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X; Li X; Zhang T; Zhao L
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):628-634. PubMed ID: 29791065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.
    Ratnaike RN; Schapel GJ; Purdie G; Rischbieth RH; Hoffmann S
    Br J Clin Pharmacol; 1986 Jul; 22(1):100-3. PubMed ID: 3091053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebral edema with hyperammonemia in valpromide poisoning. Manifestation in an adult, of a partial deficit in type I carbamylphosphate synthetase].
    Bourrier P; Varache N; Alquier P; Rabier D; Kamoun P; Lorre G; Alhayek G
    Presse Med; 1988 Nov; 17(39):2063-6. PubMed ID: 2974563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate in nonketotic hyperglycinemia.
    MacDermot K; Nelson W; Weinberg JA; Schulman JD
    Pediatrics; 1980 Mar; 65(3):624. PubMed ID: 6767222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.